Combine and conquer: Handling biotech combination inventions in the wake of KSR

Nature Biotechnology

Volumn 27, Issue 5, 2009, Pages 446-448

  Wong, Ha Kung ^a   Lau, Dana ^a  

^a Fitzpatrick Cella Harper and Scinto   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT;

ANTIBODY PRODUCTION; ART; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; ELECTRONIC SENSOR; EVALUATION; GENE THERAPY; HUMAN; LAW; PRIORITY JOURNAL; REVIEW; VALIDATION STUDY; ARTICLE; JURISPRUDENCE; PATENT; UNITED STATES;

BIOTECHNOLOGY; PATENTS AS TOPIC; SUPREME COURT DECISIONS; UNITED STATES;

EID: 66149162004     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0509-446     Document Type: Review

References (19)

1. KSR International Co. v. Teleflex, Inc., 127 S. Ct. 1727 (2007).
2. Yamanaka, M. Nat. Biotechnol. 26, 1085-1086 (2008).
3. Pfizer v. Apotex, 480 F.3d 1348 (Fed. Cir. 2007).
4. Eisai Co. v. Dr. Reddy's Labs. Ltd. 533 F.3d 1353 (Fed. Cir. 2008)
5. Graham v. John Deere Co. of Kansas City, 383 Us 1 (1966).
6. KSR v. Teleflex, 127 S. Ct. at 1739-1743.
7. KSR v. Teleflex, 127 S. Ct. at 1741.
8. In re Sullivan, 498 F.3d 1345 (Fed. Cir. 2007).
9. In re Sullivan, 498 F.3d at 1353.
10. Innogenetics NV v. Abbott Labs., 512 F.3d 1363 (Fed. Cir. 2008).
11. Innogenetics NV v. Abbott Labs., 512 F.3d at 1373.
12. Pharmastem Therapeutics v. Viacell, 491 F.3d 1342 (Fed. Cir. 2007).
13. Pharmastem Therapeutics v. Viacell, 491 F.3d at 1363.
14. Pharmastem Therapeutics v. Viacell, 491 F.3d at 1360.
15. Pharmastem Therapeutics v. Viacell, 491 F.3d at 1374-1378.
16. Pharmastem Therapeutics v. Viacell, 491 F.3d at 1378.
17. Innogenetics v. Abbott Labs., 512 F.3d at 1373.
18. KSR v. Teleflex, 127 S. Ct. at 1742.
19. Pharmastem Therapeutics v. Viacell, 491 F.3d at 1363.